Compare BGMS & ITHAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BGMS | ITHAU |
|---|---|---|
| Founded | 1996 | N/A |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | N/A |
| IPO Year | N/A | N/A |
| Metric | BGMS | ITHAU |
|---|---|---|
| Price | $0.93 | $9.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 147.8K | 21.3K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $137.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.74 | $9.94 |
| 52 Week High | $6.70 | $11.00 |
| Indicator | BGMS | ITHAU |
|---|---|---|
| Relative Strength Index (RSI) | 38.41 | 45.11 |
| Support Level | $0.74 | $9.97 |
| Resistance Level | $1.12 | $10.03 |
| Average True Range (ATR) | 0.06 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 13.95 | 3.77 |
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.